vimarsana.com

Page 7 - டொராண்டோ புனர்வாழ்வு நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vee Tech, Sona Group join Canada s UHN on wearable research

Vee Tech, Sona Group join Canada s UHN on wearable research ​ By IANS | Published on ​ Fri, Mar 5 2021 12:18 IST | ​ 0 Views Vee Tech, Sona Group join Canada’s UHN on wearable research. Image Source: IANS News Toronto, March 5 : Technology services firm Vee Technologies and Sona Group of educational institutions have signed an agreement with Toronto-based University Health Network (UHN) to develop smart fabric-based wearables. The aim is to improve the lives of people living with health-related challenges. As part of the agreement, Bengaluru and New York co-headquartered Vee Technologies will make significant cash contributions to the current and future research projects to be undertaken by the collaborating institutions, universities and hospitals in Canada.

A Canadian success story: world-first to treat Fabry disease with gene therapy

 E-Mail IMAGE: Darren Bidulka rests after his modified blood stem cells were transplanted into him at the Foothills Medical Centre in Calgary in 2017, allowing him to stop his enzyme therapy. (From. view more  Credit: Courtesy of Darren Bidulka (Thursday, Feb. 25, 2021, Toronto) Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe. The Canadian research team was the first to use gene therapy in 2017 to treat patients with Fabry disease, a rare, chronic illness that can damage major organs and shorten lives. They report their findings today in the journal

A Canadian success story: world-first to treat Fabry disease with gene therapy

A Canadian success story: world-first to treat Fabry disease with gene therapy
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

UHN launches heart failure study with Apple Watch

 E-Mail UHN launches study to explore how Apple Watch can help with early identification of worsening heart failure Renowned Canadian cardiologist Dr. Heather Ross, of the Ted Rogers Centre for Heart Research at the Peter Munk Cardiac Centre, UHN, will lead a study to learn how remote monitoring through Apple Watch can drive better clinical outcomes for heart failure patients. Toronto (February 18, 2021) - As part of the University Health Network, renowned cardiologist Dr. Heather Ross has launched a new clinical study, in collaboration with Apple to test if remote monitoring with Apple Watch can help with early identification of worsening heart failure. In this study, data collected using an Apple Watch will be compared to data routinely collected from the rigorous physical tests that patients normally undergo, to see if Apple Watch health sensors and features, including the Blood Oxygen app and mobility metrics, can provide early warning for worsening heart failure.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.